Insulin resistance mediated biochemical alterations in eye lens of neonatal streptozotocin-induced diabetic rat

Indian Journal of Experimental Biology

Volumn 49, Issue 10, 2011, Pages 749-755

  Suryanarayana, P ^a   Patil, Madhoosudan A ^a   Bhanuprakash Reddy, G ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

Animal models; Cataract; Diabetes; Eye lens; Insulin resistance

Indexed keywords

ANTIOXIDANT; CRYSTALLIN; MALONALDEHYDE; STREPTOZOCIN;

ANIMAL; ARTICLE; BLOOD; CATARACT; DIET RESTRICTION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LENS; MALE; METABOLISM; NEWBORN; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BLOOD GLUCOSE; CATARACT; CRYSTALLINS; DIABETES MELLITUS, EXPERIMENTAL; FASTING; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LENS, CRYSTALLINE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

ANIMALIA; RATTUS;

EID: 80054018039     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. McCarthy C & Taylor H, Recent developments in visionresearch, Invest Ophthalmol Vis Sci, 37 (1996) 1720.
2. Congdon N G, Friedman D S & Lietman T, Important causes of visual impairment in the world today, JAMA, 290(15) (2003) 2057.
3. Obrosova I G, Chung S S & Kador P F, Diabetic cataracts: mechanisms and management, Diabetes Metab Res Rev, 26(3) (2010) 172.
4. Mohan V, Sandeep S, Deepa R, Shah B & Varghese C, Epidemiology of type 2 diabetes: Indian scenario, Indian J Med Res,125 (2007) 217.
5. Wild S, Roglic G, Green A, Sicree R & King H, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27 (2004) 1047.
6. DeFronzo R A, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes, Diabet Rev, 5 (1997) 177.
7. Hollenbeck C & Reaven G M, Variations in insulinstimulated glucose uptake in healthy individuals with normal glucose tolerance, J Clin Endocrinol Metab, 64 (1987) 1169.
8. Reaven G M, Insulin resistance and its consequences: Type 2 diabetes and the insulin resistance syndrome. In: LeRoith D, Taylor S I, Olefsky J M, editors. Diabetes Mellitus.3rd ed. Philadelphia: Lippincott-Raven; 2004, 899.
9. Invitti C, Guzzaloni G, Gilardini L, Morabito F & Viberti G, Prevalence and concomitants of glucose intolerance in European obese children and adolescents, Diabetes Care, 26 (2003) 118.
10. Sinha R, Fisch G, Teague B, Tamborlane W V, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin R S & Caprio S, Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl J Med,346 (2002) 802.
11. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P & Gruters A, Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity a problem that is no longer restricted to minority groups, Eur J Endocrinol, 151(2004) 199.
12. Sicree R, Shaw J & Zimmet P, Prevalence and projections. In: Gan D (ed.). Diabetes Atlas International Diabetes Federation, 3rd edn. International Diabetes Federation, Brussels, Belgium, 2006; 16.
13. Ramachandran A, Snehalatha C, Shyamala P, Vijay V & Viswanathan M. High prevalence of NIDDM and IGT in an elderly south Indian population with low rates of obesity, Diabetes Care,17 (10) (1994) 1190.
14. Raghupathy P, Antonisamy B, Geethanjali F S, Saperia J, Leary S D, Priya G, Richard J, Barker D J & Fall C H, Glucose tolerance, insulin resistance and insulin secretion in young south Indian adults: Relationships to parental size, neonatal size and childhood body mass index, Diabetes Res Clin Pract, 87(2) (2010) 283.
15. Gabir M M, Hanson R L & Dabelea D, Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes, Diabetes Care, 23 (2000) 1113.
16. Brownlee M, Biochemistry and molecular cell biology of diabetic complications, Nature, 414 (2001) 813.
17. Singleton J R, Smith A G, Russell J W & Feldman E L, Microvascular complications of impaired glucose tolerance, Diabetes, 52(12) (2003) 2867.
18. Wong T Y, Barr E L, Tapp R J, Harper C A, Taylor H R, Zimmet P Z & Shaw J E, Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (Aus Diab) study, Am J Ophthalmol, 140(6) (2005) 1157.
19. Diabetes Prevention Program Research Group The prevalence of retinopathy in impaired glucose tolerance and recent onset diabetes in the Diabetes Prevention Program, Diabet Med, 24 (2007) 137.
20. Harris M I, Klein R, Welborn T A & Knuiman M W, Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis, Diabetes Care, 15(7) (1992) 815.
21. Spijkerman A M, Dekker J M, Nijpels G, Adriaanse M C, Kostense P J, Ruwaard D, Stehouwer C D, Bouter L M & Heine R J, Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study, Diabetes Care, 26(9) (2003) 2604.
22. Dugmore W N & Tun K, Glucose tolerance tests in 200 patients with senile cataract, Br J Ophthalmol, 64 (1980) 689.
23. Karasik A, Modan M, Halkin H, Treister G & Fuchs Zand Lusky A, Senile cataract and glucose intolerance: the Israel Study of glucose Intolerance Obesity and Hypertension (The Israel GOH Study), Diabetes Care, 7 (1) (1984) 52.
24. Saxena S, Mitchell P & Rochtchina E, Five-year incidence of cataract in older persons with diabetes and pre-diabetes, Ophthalmic Epidemiology, 11(4) (2004) 271.
25. Wang R N, Bouwens L & Klöppel G, Beta-cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period, Diabetologia, 39 (1996) 548.
26. Takada J, Machado M A, Peres S B, Brito L C, Borges-Silva C N, Costa C E, Fonseca-Alaniz M H, Andreotti S & Lima F B, Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass, Metabolism, 56(7) (2007) 977.
27. Andrade-Cetto A, Revilla-Monsalve C, Wiedenfeld H, Hypoglycemic effect of Tournefortia hirsutissima L., on n-streptozotocin diabetic rats, J Ethnopharmacol, 112 (2007) 96.
28. Anwer T, Sharma M, Pillai K K & Iqbal M, Effect of Withania somnifera on insulin sensitivity in non-insulindependent diabetes mellitus rats, Basic Clin Pharmacol Toxicol, 102(6)(2008) 498.
29. Liu Y, Thornton J D, Cohen M V, Downey J M & Schaffer S W, Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction, Circulation, 88 (1993) 1273.
30. Schaffer S W, & Wilson G L, Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non-insulin-dependent diabetes mellitus, Diabetologia, 36(3) (1993) 195.
31. Mather K, Surrogate measures of insulin resistance: of rats, mice, and men, Am J Physiol Endocrinol Metab, 296(2) (2009) E398.
32. Cacho J, Sevillano J, de Castro J, Herrera E, & Ramos M P, Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats, Am J Physiol Endocrinol Metab, 295(5) (2008) E1269.
33. Suryanarayana P, Saraswat M, Mrudula T, Krishna T P, Krishnaswamy K & Reddy G B, Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats, Invest Ophthalmol Vis Sci, 46(6) (2005) 2092.
34. Suryanarayana P, Saraswat M, Petrash J M & Reddy G B, Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats, Mol Vis, 13 (2007) 1291.
35. Reddy G B, Reddy P Y, Vijayalakshmi A, Kumar M S, Suryanarayana P & Sesikeran B, Effect of long-term dietary manipulation on the aggregation of rat lens crystallins: role of alpha-crystallin chaperone function, Mol Vis, 8 (2002) 298.
36. Schaffer S W, Cherry Ballard-Croft, Scott Boerth & Simon N, Allo Mechanisms underlying depressed NaqrCa2q exchanger activity in the diabetic heart, Cardiovascular Research, 34 (1997) 129.
37. Sartoretto J L, Melo G A, Carvalho M H, Nigro D, Passaglia R T, Scavone C, Cuman R K & Fortes Z B, Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression, Life Sciences, 77 (2005) 2676.
38. Shinde U A & Goyal R K, Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats, J Cell Mol Med, 7(3) (2003) 322.
39. Schaffer S W & Wilson G I, Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non-insulin-dependent diabetes mellitus, Diabetologia, 36 (1993) 195.
40. de Oliveira C A, Luciano E & de Mello M A, The role of exercise on long-term effects of alloxan administered in neonatal rats, Exp Physiol, 90(1) (2005) 79.
41. Ribeiro C, de Oliveira C A, Luciano E & de Mello M A, Diabetes evolution in rats after neonatal treatment with alloxan, Res Commun Mol Pathol Pharmacol, 117-118 (2005) 29.
42. Suryanarayana P, Krishnaswamy K & Reddy G B, Effect of curcumin on galactose-induced cataractogenesis in rats, Mol Vis, 9 (2003) 223.
43. Kador P F & Kinoshita J H, Diabetic and galactosaemic cataracts, Ciba Found Symp, 106 (1984) 110.
44. Gonzalez A M, Sochor M & McLean P, The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats, Diabetes, 32(1983) 482.
45. Obrosova I G, Fathallah L & Lang H J, Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor, Biochem Pharmacol, 58(12) (1999) 1945.
46. Obrosova I G & Stevens M J, Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens, Invest Ophthalmol Vis Sci, 40(3) (1999) 680.
47. Obrosova I G, Fathallah L. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study, Diabetologia, 43(8) (2000) 1048.
48. Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, Kato M, Ohshima M & Nagao A, The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects, J Epidemiol, 16(2) (2006) 71.
49. Chiavaroli V, Giannini C, D'Adamo E, de Giorgis T, Chiarelli F & Mohn A, Insulin resistance and oxidative stress in children born small and large for gestational age, Pediatrics, 124(2) (2009) 695.
50. Park K, Gross M, Lee D H, Holvoet P, Himes J H, Shikany J M & Jacobs D R Jr., Oxidative Stress and Insulin Resistance: The coronary artery risk development in young adults study, Diabetes Care July, 32(2009)1302.
51. Balasaraswathi K, Rajasekar P & Anuradha C V, Changes in redox ratio and protein glycation in precataractous lens from fructose-fed rats: effects of exogenous L-carnitine, Clin Exp Pharmacol Physiol, 35(2) (2008) 168.